League Connect Digital Summit on May 7

I’m thrilled to be working with League and I’ll be MC-ing health care’s must-attend virtual CX event, League Connect Digital Summit on May 7.  An immersive day of inspiration, insights, and incredible speakers is headlined by Moneyball & Big Short Best-Selling Author, Michael Lewis and @HighmarkHealth CEO, @DavidHolmberg, as well as many more. More than…

Read More

Pre-Surgical Complications (Part 6) — The Decision

By MATTHEW HOLT Strap in for the tale of why your hero is spending most of his life down YouTube rabbit holes of cardiology videos while blundering his way around many many medical centers and exposing many problems with American health care even before he gets close to the operating table. Yes it’s Matthew Holt’s…

Read More

Do orphan drugs deliver more survival gains per patient than non-orphan drugs?

Conventional wisdom holds that orphan drugs treat rare (by definition) and more severe diseases. Because they treat diseases with significant unmet needs, their health benefits per person are large. But are they really? Does conventional wisdom align with the evidence? To answer the question myself and colleagues at FTI Consulting, including co-author Marie Steele-Adjognon, conducted…

Read More

Why Providers Are Stalling When It Comes to Scaling AI

Without a clear picture of which solutions are working and which ones aren’t, it’s difficult for providers to scale AI across their enterprise. As hospitals transition their AI efforts from experimentation mode to the widespread adoption phase, experts agree that more rigorous, real-world evidence is needed. The post Why Providers Are Stalling When It Comes…

Read More